Pulmonary Vein Isolation Outcomes With Fish Oils
NCT00841451 · Status: NO_LONGER_AVAILABLE · Type: EXPANDED_ACCESS
Last updated 2016-03-23
Summary
Fish oil therapy may decrease the incidence of cardiac arrhythmias. This study will test whether pre-treatment with fish oils before catheter ablation of atrial fibrillation decreases the early post operative occurrence of atrial fibrillation.
Conditions
Interventions
- DRUG
-
Lovaza (Fish Oils)
Double blinded placebo controlled
Sponsors & Collaborators
- collaborator INDUSTRY
-
St. Luke's-Roosevelt Hospital Center
lead OTHER
Principal Investigators
-
Suneet Mittal, MD · St. Luke's-Roosevelt Hospital Center
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
Countries
- United States
Study Locations
More Related Trials
-
Fish Oil for Reduction of Atrial Fibrillation After Cardiac Surgery
NCT00446966 ·Status: COMPLETED ·Phase: PHASE4
-
Omega 3 Fatty Acids and Atrial Fibrillation
NCT00508248 ·Status: WITHDRAWN ·Phase: NA
-
Eicosapentaenoic Acid (EPA)and Docosahexaenoic Acid Study
NCT01400490 ·Status: UNKNOWN ·Phase: NA
-
Fatty Acid Antiarrhythmia Trial (FAAT)
NCT00004559 ·Status: COMPLETED ·Phase: PHASE3
-
Fish Oil and Biomarkers of Cardiovascular Risk
NCT00527436 ·Status: TERMINATED ·Phase: NA
-
Omega 3 Polyunsaturated Fatty Acid Supplements (PUFAs) and Microvolt T Wave Alternans (TWA) in Patients With Ventricular Arrhythmia
NCT00507390 ·Status: WITHDRAWN ·Phase: PHASE4
-
Effect of Supplemental Intake of Omega-3 Polyunsaturated Fatty Acids on the Rate and Complexity of Spontaneously Occurring Ventricular and Supraventricular Arrhythmias in Patients With Implantable Cardioverter Defibrillator (ICD) - A Randomized Clinical Trial
NCT00290056 ·Status: UNKNOWN ·Phase: PHASE4
-
Omega-3 Fatty Acids for Prevention of Post-Operative Atrial Fibrillation
NCT00970489 ·Status: COMPLETED ·Phase: PHASE3
-
The Triglyceride Lowering Effect of an Omega-3 Fat (DHA) in Addition to Statin Therapy for Patients With CAD or Diabetes
NCT00360217 ·Status: COMPLETED ·Phase: NA
-
Do Fish Oils Prevent Restenosis Post-Coronary Angioplasty?
NCT00000473 ·Status: COMPLETED ·Phase: PHASE3
-
Differential Thrombogenesis by EPA and DHA Mediated by HDL
NCT06494488 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Fish Oils and Adipose Inflammation Reduction
NCT02010359 ·Status: COMPLETED ·Phase: PHASE4
-
Multi_center Study to Evaluate the Effect of N-3 Fatty Acids (OMEGA-3) on Arrhythmia Recurrence in Atrial Fibrillation
NCT01235130 ·Status: COMPLETED ·Phase: PHASE3
-
Fish Oil In Heart Transplantation
NCT01072994 ·Status: UNKNOWN ·Phase: NA
-
n-3 Polyunsaturated Fatty Acids (PUFAs) in the Prevention of Atrial Fibrillation
NCT01198275 ·Status: COMPLETED ·Phase: PHASE3
-
Fish Oil Versus Statins Versus Placebos in Reducing Atrial Fibrillation in Patients Undergoing Thoracic Surgery for Lung Cancer
NCT01259284 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
Fenofibrate and Omega-3 Fatty Acid Modulation of Endotoxemia
NCT01048502 ·Status: COMPLETED ·Phase: NA
-
The ALA, DHA and EPA Esters in the Prevention of Cardiovascular Diseases.
NCT04743050 ·Status: UNKNOWN ·Phase: PHASE3
-
Randomized Trial to Assess Efficacy of PUFA for the Maintenance of Sinus Rhythm in Persistent Atrial Fibrillation
NCT00597220 ·Status: UNKNOWN ·Phase: PHASE3
-
Effects of Omega-3 Fatty Acids on Platelets in Patients With Coronary Artery Disease With Hypertriglyceridemia
NCT01086163 ·Status: UNKNOWN
-
Effect of High Dose Fish Oil Supplementation After Recent Heart Attack Using Magnetic Resonance Imaging
NCT00729430 ·Status: COMPLETED ·Phase: PHASE3
-
Intravenous n-3 Fatty Acids and Ventricular Tachycardia in Patients With Implantable Cardioverter Defibrillator (ICD)-Pacemaker
NCT00534300 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Omega 3 Fatty Acid Efficiency for Prevention of Atrial Fibrillation After Coronary Artery Bypass Grafting
NCT01175330 ·Status: TERMINATED ·Phase: PHASE3
-
Evaluating the Relationship Between Fatty Acids and Heart Disease
NCT00404872 ·Status: COMPLETED
-
Efficacy of Omega-3 Fatty Acid Therapy in Preventing Gastrointestinal Bleeding in Patients With CF-LVAD
NCT03784963 ·Status: TERMINATED ·Phase: PHASE1/PHASE2